ASAleksandr A. Sychev

Aleksandr A. Sychev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandr A. Sychev has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical presentation of brain abscesses: from classic triad to silent forms

    by A.I. Baranich, A.A. Sychev, I.A. Savin, N.V. Kurdyumova, M.V. Sukhorukova, D.N. Andreev, O.I. Sharipov, Z.SH. Veliev, D.S. Korotkov

    Despite relatively small incidence, brain abscesses are life-threatening with high risk of death and persistent neurological deficits. A key factor limiting early diagnosis is polymorphic and nonspecific clinical presentation. Objective. To analyze the structure and incidence of clinical symptoms in a cohort of patients with brain abscesses treated at the Burdenko Neurosurgical Center. Material and methods. A single-center study was based on medical records of patients with newly diagnosed and confirmed brain abscesses hospitalized for surgical treatment at the Burdenko Neurosurgery Center between January 2022 and December 2025. Verification was based on contrast-enhanced MRI and/or intraoperative data. Results. The study included 41 patients with verified intracranial abscesses. The most common symptoms were headache (51.2%) and focal neurological deficit (48.8%). Fever was detected in 19.5% of patients, classic triad (headache, focal neurological deficit, fever) — in only 7.3% of patients. There were no symptoms (subclinical presentation) in 19.5% of patients. Atypical and silent forms of disease comprised 73.2%. Conclusion. Silent and atypical forms account for 73.2% of cases, while classic triad of symptoms is recorded in only 7.3% of patients. This decreases its diagnostic value. In this regard, patients with focal neurological symptoms or severe headaches, even afebrile cases, and previous possible cause of infection (otitis, sinusitis, odontogenic infection, etc.) seem reasonable not only to have brain abscess but also be scheduled for neuroimaging with specialized modes.

  • Vitamin K deficiency in critically ill patients

    by A.I. Baranich, A.A. Sychev, I.A. Savin, O.A. Gadzhieva, V.G. Kudrina

    Maintaining hemostasis balance in critically ill patients is one of the most complex clinical challenges. Among many factors influencing coagulation, vitamin K is an essential cofactor in synthesis of key proteins of blood clotting system. Vitamin K deficiency in ICU patients is still a largely underestimated problem, and clinical approaches are limited to vitamin K correction only in patients with hemorrhagic complications via intake of vitamin K antagonists. This review is devoted to vitamin K deficiency in critically ill patients, including risk factors, prevention and treatment.

  • Clinical and prognostic value of IL-6 and IL-2 monitoring in patients with severe traumatic brain injury

    by A.A. Sychev, I.A. Savin, G.V. Danilov, A.I. Baranich, K.O. Kakurin, Yu.V. Strunina, A.V. Oshorov, A.D. Kravchuk

    Traumatic brain injury (TBI) is characterized by high mortality and severe disability worldwide representing a major social, economic, and medical problem. Pathogenesis of secondary brain damage is underpinned by a cascade of neuroinflammatory reactions triggered by cytokine release. Key mediators include interleukin-6 (IL-6) and interleukin-2 (sIL-2R) system. However, their daily dynamics in acute period of severe trauma and relationship with intracranial hypertension remain poorly understood. Material and methods. The study was conducted at the Burdenko Neurosurgical Center. Inclusion criteria: acute TBI, admission within 24 hours, age 18—75 years. Exclusion criteria: atonic coma, decompensation of chronic diseases. IL-6, sIL-2R, C-reactive protein, and procalcitonin were assessed. Results. There were 74 patients with severe TBI (19 women, mean age 34.0±12.5 years). The mortality rate was 14.9% (11 patients). Biphasic cytokine dynamics was revealed. Early increase in IL-6 on day 1 reflected extent of primary injury. On the 2nd day, IL-6 levels remained significantly higher in patients with fatal outcome (median 40.2 vs. 22.4 pg/ml, p<0.05). Secondary increase was recorded after 3 days and coincided with manifestation of infectious complications peaking on day 5. On day 5, sIL-2R levels were found to be more than 2.5-fold higher in patients with fatal outcome (1660.0 vs. 649.0 pg/ml, p<0.05). In fatal patients, we found strong direct correlation between IL-6 and intracranial pressure (rho=0.71), as well as inverse correlation with cerebral perfusion pressure. Conclusion. Biphasic cytokine response develops in acute phase of severe traumatic brain injury. Early phase (2 days) is characterized by increased IL-6 according to extent of primary cerebral injury. The second phase (days 3—14) is associated with infectious complications and characterized by increased sIL-2R and IL-6. It is not their absolute value, but temporal dynamics is prognostically significant. No IL-6 reduction by 48 hours after injury indicates uncontrollable neuroinflammation and potentially unfavorable outcomes. Peak (more than 2.5 times) increase in sIL-2R on day 5 is a marker of transformation of protective inflammation into systemic hyperinflammatory syndrome. Direct correlation between IL-6 and intracranial hypertension in fatal patients confirms pathogenetic role of this cytokine in secondary brain injury. IL-6 and sIL-2R monitoring may enable timely identification of patients with high risk of fatal intracranial hypertension and ensure a personalized approach to intensive care.

  • Causes and microbiological spectrum of brain abscesses: modern data

    by A.I. Baranich, A.A. Sychev, I.A. Savin, N.V. Kurdyumova, M.V. Sukhorukova, Z.SH. Veliev, D.S. Korotkov, K.O. Kakurin, V.G. Kudrina

    Brain abscesses are relatively rare, yet they are life-threatening infections with high risk of persistent neurological impairment in survivors. Effectiveness of therapy depends on understanding the range of probable pathogens. This enables optimal empirical therapy avoiding broad-spectrum combinations and associated risks of drug-drug interactions. Available Russian literature predominantly contains case reports and reviews resulting in a lack of up-to-date epidemiological data on brain abscesses. Objective. To analyze current etiological and epidemiological data in a cohort of patients with verified brain abscesses. Material and methods. A single-center retrospective study enrolled 41 patients with primary brain abscesses between 2022 and 2025. The diagnosis was confirmed by contrast-enhanced MRI and/or intraoperative findings. Exclusion criteria: extracranial abscess, concomitant intracranial or head soft tissue infection and recurrent abscesses. Results. Abscesses occurred as complications of neurosurgery in 16 (39%) out of 41 patients, ENT diseases — in 4 (9.8%) cases. Odontogenic route of infection was established in 4 (9.8%) cases, and 2 (4.9%) patients had previous traumatic brain injury. Etiology was unknown in 36.6% of cases. Gram-positive cocci prevailed: Staphylococcus spp. (26.8%) and Streptococcus spp. (19.5%). Conclusion. These data highlight the need for regular updating of local epidemiological data on brain abscesses. A thorough analysis of anamnestic data in these patients can enable informed and timely prescription of appropriate empirical antimicrobial therapy. Choice of this therapy depends crucially on spectrum of probable pathogens, especially in the absence of microbiological verification.

  • Systemic thrombolysis in postoperative neurosurgical patients with massive pulmonary embolism (case series and review)

    by A.I. Baranich, A.A. Sychev, S.B. Yakovlev, I.A. Savin, Z.SH. Veliev, T.A. Abramov, N.V. Kurdyumova, D.S. Korotkov, V.G. Kudrina

    Neurosurgical patients represent a high-risk group for pulmonary embolism (PE). Patients with PE and high risk of death require immediate reperfusion therapy—mechanical reperfusion or systemic thrombolysis. Thrombolytic therapy (TLT) provides rapid reduction of obstruction and decreases pulmonary artery pressure, but it is associated with high risk of hemorrhagic complications. An absolute contraindication for TLT is central nervous system disease. When choosing a treatment strategy, one should consider PE-related risk of death with likelihood and consequences of intracranial hemorrhage. This article describes TLT in neurosurgical patients with massive PE and high risk of death over a 4.5-year follow-up period.

  • Correction of the effect of direct oral and parenteral anticoagulants in hemorrhagic stroke

    by A.I. Baranich, A.A. Sychev, I.A. Savin, V.G. Kudrina, A.V. Kozlov

    Background. Hemorrhagic stroke is associated with high risk of adverse outcome and follows intake of anticoagulants and antiplatelet agents in 25% of cases. The latest clinical guidelines of the Neurocritical Care Society for correction (reversal) of the effect of anticoagulants and antiplatelet agents in hemorrhagic stroke were published in 2016. Material and methods. In accordance with PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases to a depth of 5 years and selected 48 articles. Results and discussion. Direct oral anticoagulants are currently common. To reverse their effect, one can use specific antidotes (idarucizumab is recommended for dabigatran, andexanet alfa (not yet registered In Russia) for factor Xa inhibitors (rivaroxaban, apixaban)) and combination of prothrombin complex concentrate and tranexamic acid. Protamine sulfate is antidote for unfractionated and low molecular weight heparins. Protamine sulfate completely inactivates unfractionated heparin, but it is less effective against low molecular weight heparin. It is characterized by high probability of anaphylactic reactions, especially after repeated administrations. The effectiveness of andexanet alpha and activated factor VII for reversing the effect of low molecular weight heparin is being studied. Fondaparinux sodium is used for heparin-induced thrombocytopenia. Protamine sulfate is ineffective for reversing the effect of fondaparinux. One can use prothrombin complex concentrate and andexanet alpha, but their effectiveness is unclear. Ciraparantag is being studied in clinical trials. Apparently, ciraparantag is highly effective as an antidote for various anticoagulants. Conclusion. Early hemostatic therapy and reversal of anticoagulant effects in patients with hemorrhagic stroke significantly reduce the risk of adverse outcomes. This problem is being studied. Regular literature review with creation of updated clinical guidelines is needed.


  • Microbial etiology of early-onset pneumonia in acute period of severe traumatic brain injury

    by A.A. Sychev, A.I. Baranich, I.A. Savin, O.N. Ershova, G.V. Danilov, Yu.V. Strunina, N.V. Kurdyumova, E.YU. Sokolova, M.V. Sukhorukova, D.A. Milekhina, et al.

    Despite modern advances in intensive care and epidemiology, patients with severe traumatic brain injury (TBI) have high risk of infectious complications. According to some studies, the most common infection in these patients is pneumonia. Objective. To assess changes in etiology and resistance of pathogens of early pneumonia in acute period of severe TBI. Material and methods. A prospective observational study was carried out between 2010 and 2021. The study included 94 patients aged 18—75 years in acute period of severe TBI (GCS score <8). There were 69 men. All patients were transferred from primary hospital within 72 hours after TBI. Microbiological tests of blood, urine and endotracheal aspirate were performed in all patients upon admission with further assessment of antibiotic resistance of pathogens. Results. Over the past years, gram-negative carbapenem-resistant flora including Acinetobacter baumannii and Klebsiella pneumoniae prevailed as pathogens of early pneumonia in acute period of TBI. The most common causative agent of early pneumonia among gram-positive flora is Staphylococcus aureus. More than 25% of these cases are characterized by resistance to oxacillin. Conclusion. In recent years, the number of resistant strains of A. baumanii, Kl. pneumoniae and S. aureus causing early pneumonia in acute period of TBI is steadily increasing. Analysis of epidemiological profile of in-hospital infectious complications is extremely important for rational approaches to early empirical antibacterial therapy. Early diagnosis of antibacterial resistance is a fundamental factor for effective antibacterial therapy.

  • Correction of the effect of vitamin K antagonists and antiplatelet agents in hemorrhagic stroke

    by A.I. Baranich, A.A. Sychev, I.A. Savin, V.G. Kudrina, A.V. Kozlov

    Background. Hemorrhagic stroke (HS) is associated with high risk of mortality or disability. To date, up to 25% of HSs are associated with anticoagulants and antiplatelet agents. Early hemostatic therapy and correction of effect of antithrombotic drugs in patients with HS significantly reduce the risk of adverse outcomes. The latest international guidelines on this issue were presented almost 10 years ago. Material and methods. In accordance with the PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases and identified 137 articles. Of these, 52 were enrolled as the most relevant. Results and discussion. Regarding correction of the effect of indirect anticoagulants, various researchers discuss the possibility of either individual dosing or injection of a fixed dose of 4- or 3-factor prothrombin complex (1000—2000 IU regardless of body weight and international normalized ratio). To correct the effect of antiplatelet agents, platelet transfusion and desmopressin are proposed. There is currently no evidence of safety and effectiveness of both methods in patients with HS. Conclusion. The optimal drug for correction of the effect of indirect anticoagulants is 4- or 3-factor prothrombin complex. In the last case, it is necessary to administer factor VIIa or fresh frozen plasma, as well as parenteral form of phytomenadione (vitamin K1) in all cases. The issue of correction of the effects of antiplatelet agents remains open. Regular analysis of available data with updating the guidelines for correction of the effect of anticoagulants and antiplatelet agents in HS is necessary.


  • Puncture dilatation tracheostomy in children during transoral neurosurgical interventions

    by E.P. Ananyev, A.A. Sychev, A.A. Pashin, A.N. Shkarubo, I.A. Savin, A.S. Goryachev

    Neurosurgical interventions within the ventral surface of the clivus and upper cervical vertebrae in childhood are sometimes carried out through transoral approach. In this situation, tracheostomy is safer for airway protection and mechanical ventilation compared to prolonged intubation. The world experience of percutaneous dilation tracheostomy in pediatric patients is limited due to anatomical and physiological features, such as difficult orientation in anatomical landmarks, high mobility of the trachea and small tracheal lumen. Also, the trachea easily collapses when pressed in pediatric patients that complicates safe puncture of anterior wall and can lead to perforation of posterior tracheal wall. Objective. To describe a modified technique of video-assisted percutaneous dilation tracheostomy using additional thin guide and dilator in children of primary school age. Material and methods. We considered 11 patients aged 6-12 years who underwent video-assisted percutaneous dilation tracheostomy. Results. There were no perioperative complications (bleeding, false course, perforation of posterior tracheal wall). Infection of tracheostomy, fistulas or tracheal stenosis was absent. Conclusion. Percutaneous dilation tracheostomy may be alternative to classical surgical tracheostomy for pediatric patients. Endoscopic control and certain technical changes of percutaneous tracheostomy are necessary and provide safe manipulation. Surgery time, less trauma and minimal cosmetic defect after tracheostomy are significant advantages of this technique compared to surgical tracheostomy.

  • Open Access

    Thromboelastometry-Based Prophylaxis for Venous Thromboembolism in the Acute Period Following Isolated Severe Traumatic Brain Injury

    by Anastasia I. Baranich, Aleksandr A. Sychev, Ivan A. Savin, Gleb V. Danilov, Yulia V. Strunina

    Baranich AI, et al. Korean J Neurotrauma. 2024 Mar;20(1):45-51. https://doi.org/10.13004/kjnt.2024.20.e10